BioCryst Pharmaceuticals Inc (BCRX)
US$ 8.223.27%
Price Chart
Key Statistics
Market Cap
$ 1.74B
P/E Ratio
0.00
Revenue (TTM)
$ 450.71M
Volume
3.25M
52W High
$ 9.50
52W Low
$ 4.15
Dividend Yield
0.00%
Beta
1.75
Technicals
50-Day MA
7.8384
200-Day MA
7.7508
52 Week High
9.5
52 Week Low
4.15
About BCRX
BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases.
Employees
580
Headquarters
Durham, NC
CEO
Mr. Jon P. Stonehouse
Latest News
BioCryst (BCRX) Coverage Initiated with Optimistic Outlook | BCR - GuruFocus
Yesterday • Google News
BioCryst Awards Strategic RSU Grants to 10 New Employees: Growth Plans Revealed - Stock Titan
4 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg